Journal of Vaccine Trials

Journal of Vaccine Trials is an international peer-reviewed, online-accessible, open access compendium of high impact manuscripts.

Aims and Scope

The widely acclaimed Journal of Vaccine Trials provides an open academic forum for the exchange of scientific ideas and concepts among scholars worldwide. Journal of Vaccine Trials publishes critically-selected peer-reviewed research manuscripts seeking to advance Human Vaccines, Clinical Trials, Treatment Trials, Quality Assurance, Clinical Pharmacology, and Diagnosis of Disease. We seek to inspire the dissemination of novel ideas and concepts endeavoring to push the Frontiers of Vaccine Trials to new heights. We seek to attract contributions from the most distinguished authorities in respective subdisciplines, while providing junior investigators with a forum to present their ideas. The manuscripts are critically reviewed by world-renowned Editors and Reviewers seeking to help authors generate widely-cited articles. We are actively applying to have the journal cited in PubMed, Medline, and Scimago databases.

Ownership

The journal is owned by Acquaint Publications.

Open Access

Articles published by the Journal of Vaccine Trials are made openly, freely, and permanently accessible online immediately commencing from the date of publication. Please refer to open access for further information. We publish manuscripts under a Creative Commons Attribution 4.0 International License (CC-BY). The CC-BY permits maximal dissemination of open access materials, preferred by many investigators and research funding bodies. Under the tenets of this license, users are free to copy, distribute, transmit, and remix (adapt) the contribution for any set of purposes, even commercially, provided the users appropriately acknowledge the original authors and the funding source.
Authors retain copyright of their work and the rights to make specified re-uses of the works.

Editorial Board

Please see Editorial Board Members.

Editorial Policies

All manuscripts submitted to the Journal of Vaccine Trials should conform to OAE's Editorial Policies.

Peer Review

The Journal of Vaccine Trials adheres to rigorous peer review processes and undergoes double-blinded peer review. Please see Author Guidelines.

Publication Ethics Statement

The Journal of Vaccine Trials is membered with other sister journals under Committee on Publication Ethics (COPE). We completely adhere to its Code of Conduct and Best Practice Guidelines.

The Editorial Board Members of the Journal of Vaccine Trials enforce a rigorous peer-review process coupled with strict ethical policies and standards in order to ensure we include only the highest quality scientific works to the respective sub-disciplines of scholarly publication. We rapidly identify and quench attempts at plagiarism, data misrepresentation, injudicious image modification, and inappropriate author lists. We employ Crosscheck (powered by iThenticate) in order to confirm originality of submissions

Journal Information and Statistics

  • Launch date: March 1, 2020
  • Publication: Open access
  • Frequency: Bi-monthly journal
  • DOI: (10.31579)

Indexing/Abstracting

Articles published in the Journal of Vaccine Trials are included in google scholar etc.

Please contact us for details about different queries.

 

  Indexed in